首站-论文投稿智能助手
典型文献
Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
文献摘要:
Amplifying"eat me signal"during tumor immunogenic cell death(ICD)cascade is crucial for tumor immunotherapy.Inspired by the indispensable role of adenosine triphosphate(ATP,a necessary"eat me signal"for ICD),a versatile ICD amplifier was developed for chemotherapy-sensitized immuno-therapy.Doxorubicin(DOX),ATP and ferrous ions(Fe2+)were co-assembled into nanosized amplifier(ADO-Fe)through π-π stacking and coordination effect.Meanwhile,phenylboric acid-poly ethylene gly-col-phenylboric acid(PBA-PEG-PBA)was modified on the surface of ADO-Fe(denoted as PADO-Fe)by the virtue of D-ribose unit of ATP.PADO-Fe could display active targetability against tumor cells via sialic acid/PBA interaction.In acidic microenvironment,PBA-PEG-PBA would dissociate from amplifier.Moreover,high H2O2 concentration would induce hydroxyl radical(·OH)and oxygen(O2)generation through Fenton reaction by Fe2+.DOX and ATP would be released from the amplifier,which could induce ICD effect and"ICD adjuvant"to amplify this process.Together with programmed death ligands 1(PD-L1)checkpoint blockade immunotherapy,PADO-Fe could not only activate immune response against primary tumor,but also strong abscopal effect against distant tumor.Our simple and multifunc-tional ICD amplifier opens a new window for enhancing ICD effect and immune checkpoint blockade therapy.
文献关键词:
作者姓名:
Jiulong Zhang;Xiaoyan Sun;Xiufeng Zhao;Chunrong Yang;Menghao Shi;Benzhuo Zhang;Haiyang Hu;Mingxi Qiao;Dawei Chen;Xiuli Zhao
作者机构:
School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China;Department of Oncology,Affiliated Hongqi Hospital of Mudanjiang Medical College,Mudanjiang 157011,China;Department of Pharmacy,Shantou University Medical College,Shantou 515041,China;Department of Neurology,The Second Affiliated Hospital of Mudanjiang Medical College,Mudanjiang 157009,China
引用格式:
[1]Jiulong Zhang;Xiaoyan Sun;Xiufeng Zhao;Chunrong Yang;Menghao Shi;Benzhuo Zhang;Haiyang Hu;Mingxi Qiao;Dawei Chen;Xiuli Zhao-.Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy)[J].药学学报(英文版),2022(09):3694-3709
A类:
Amplifying,phenylboric,PADO,targetability
B类:
Combining,immune,checkpoint,blockade,ATP,immunogenic,death,amplifier,cancer,immunotherapy,signal,during,tumor,ICD,cascade,crucial,Inspired,by,indispensable,role,adenosine,triphosphate,necessary,versatile,was,developed,chemotherapy,sensitized,Doxorubicin,DOX,ferrous,ions,Fe2+,were,assembled,into,nanosized,through,stacking,coordination,effect,Meanwhile,poly,ethylene,gly,col,PBA,PEG,modified,surface,denoted,virtue,ribose,unit,could,display,active,against,cells,via,sialic,interaction,acidic,microenvironment,would,dissociate,from,Moreover,high,H2O2,concentration,induce,hydroxyl,radical,oxygen,generation,Fenton,reaction,be,released,which,adjuvant,amplify,this,process,Together,programmed,ligands,L1,only,activate,response,primary,but,also,strong,abscopal,distant,Our,simple,multifunc,tional,opens,new,window,enhancing
AB值:
0.519874
相似文献
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang;Xi Jiao;Shuang Li;Huan Chen;Xin Wei;Chang Liu;Jifang Gong;Xiaotian Zhang;Xicheng Wang;Zhi Peng;Changsong Qi;Zhenghang Wang;Yanni Wang;Na Zhuo;Jianling Zou;Henghui Zhang;Jian Li;Lin Shen;Zhihao Lu-Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Gastric&Colorectal Surgery,The First Hospital of Jilin University,Changchun 130021,China;Genecast Precision Medicine Technology Institute,Beijing 100192,China;Life Sciences Institute,Zhejiang University,Hangzhou 310058,China;Institute of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China
Supramolecular engineering of cell membrane vesicles for cancer immunotherapy
Shaolong Qi;Haiyan Zhang;Xueyan Zhang;Xinyang Yu;Yajun Wang;Qian-Fang Meng;Kai Yang;Bing Bai;Rui Tian;Shoujun Zhu;Lang Rao;Feihe Huang;Guocan Yu-Key Laboratory of Bioorganic Phosphorus Chemistry&Chemical Biology,Department of Chemistry,Tsinghua University,Beijing 100084,China;State Key Laboratory of Supramolecular Structure and Materials,College of Chemistry,Jilin University,Changchun 130012,China;Institute of Biomedical Health Technology and Engineering,Shenzhen Bay Laboratory,Shenzhen 518132,China;State Key Laboratory of Chemical Engineering,Stoddart Institute of Molecular Science,Department of Chemistry,Zhejiang University,Hangzhou 310027,China;ZJU-Hangzhou Global Scientific and Technological Innovation Center,Hangzhou 311215,China;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,Center for Molecular Imaging and Translational Medicine School of Public Health,Xiamen University,Xiamen 361102,China
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He;Xinxin Xiong;Han Yang;Dandan Li;Xuefei Liu;Shuo Li;Shuangye Liao;Siyu Chen;Xizhi Wen;Kuai Yu;Lingyi Fu;Xingjun Dong;Kaiyu Zhu;Xiaojun Xia;Tiebang Kang;Chaochao Bian;Xiang Li;Haiping Liu;Peirong Ding;Xiaoshi Zhang;Zhenjiang Liu;Wende Li;Zhixiang Zuo;Penghui Zhou-State Key Laboratory of Oncology in Southern China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,China;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Laboratory Animals Monitoring Institute,Guangdong Key Laboratory of Laboratory Animals,Guangzhou,China;Guangzhou Finelmmune Biotechnology Co.,LTD,Guangzhou,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。